Related Experiment Video
Updated: Mar 25, 2026

Bone Conditioned Medium: Preparation and Bioassay
Published on: July 8, 2015
Bone health nutraceuticals alter microarray mRNA gene expression: A randomized, parallel, open-label clinical study
Yumei Lin1, Valentina Kazlova2, Shyam Ramakrishnan3
1Nutrilite Health Institute, Amway R&D, 5600 Beach Boulevard, Buena Park, CA 90622, United States; Yumei Consulting, Inc., P.O. Box 821, Huntington Beach, CA 92648, United States.
Background And Objective:
Dietary intake of fruits and vegetables has been suggested to have a role in promoting bone health. More specifically, the polyphenols they contain have been linked to physiological effects related to bone mineral density and bone metabolism. In this research, we use standard microarray analyses of peripheral whole blood from post-menopausal women treated with two fixed combinations of plant extracts standardized to polyphenol content to identify differentially expressed genes relevant to bone health.
Methods:
In this 28-day open-label study, healthy post-menopausal women were randomized into three groups, each receiving one of three investigational fixed combinations of plant extracts: an anti-resorptive (AR) combination of pomegranate fruit (Punica granatum L.) and grape seed (Vitis vinifera L.) extracts; a bone formation (BF) combination of quercetin (Dimorphandra mollis Benth) and licorice (Glycyrrhiza glabra L.) extracts; and a fixed combination of all four plant extracts (AR plus BF). Standard microarray analysis was performed on peripheral whole blood samples taken before and after each treatment. Annotated genes were analyzed for their association to bone health by comparison to a gene library.
Results:
The AR combination down-regulated a number of genes involved in reduction of bone resorption including cathepsin G (CTSG) and tachykinin receptor 1 (TACR1). The AR combination also up-regulated genes associated with formation of extracellular matrix including heparan sulfate proteoglycan 2 (HSPG2) and hyaluronoglucosaminidase 1 (HYAL1). In contrast, treatment with the BF combination resulted in up-regulation of bone morphogenetic protein 2 (BMP-2) and COL1A1 (collagen type I α1) genes which are linked to bone and collagen formation while down-regulating genes linked to osteoclastogenesis. Treatment with a combination of all four plant extracts had a distinctly different effect on gene expression than the results of the AR and BF combinations individually. These results could be due to multiple feedback systems balancing activities of osteoblasts and osteoclasts.
Conclusion:
In summary, this ex-vivo microarray study indicated that the pomegranate, grape seed, quercetin and licorice combinations of plant extracts modulated gene expression for both osteoclastic and osteogenic processes.
Insights
Plant extracts from pomegranate, grape seed, quercetin, and licorice modulated genes involved in bone health. This study identified effects on bone resorption and formation pathways in post-menopausal women.
Area of Science:
- Nutrigenomics
- Bone Biology
- Pharmacology
Background:
- Dietary polyphenols from fruits and vegetables may promote bone health.
- Polyphenols are linked to bone mineral density and metabolism.
- Gene expression analysis can reveal mechanisms of action for plant extracts.
Purpose of the Study:
- To investigate the effects of plant extracts on gene expression related to bone health.
- To identify differentially expressed genes in post-menopausal women treated with specific plant extract combinations.
Main Methods:
- A 28-day open-label study involving healthy post-menopausal women.
- Randomization into three groups receiving anti-resorptive (AR), bone formation (BF), or combined (AR+BF) plant extracts.
- Standard microarray analysis of peripheral whole blood samples before and after treatment.
Main Results:
- The AR combination down-regulated genes for bone resorption (e.g., CTSG, TACR1) and up-regulated extracellular matrix formation genes (e.g., HSPG2, HYAL1).
- The BF combination up-regulated bone formation genes (e.g., BMP-2, COL1A1) and down-regulated osteoclastogenesis genes.
- The combined extract showed distinct gene expression patterns, suggesting complex regulatory feedback.
Conclusions:
- Pomegranate, grape seed, quercetin, and licorice extracts modulate gene expression in both osteoclastic and osteogenic processes.
- These findings provide insight into the molecular mechanisms by which plant-derived polyphenols may influence bone metabolism.
- Further research can explore the therapeutic potential of these extracts for bone health.
More Related Videos
04:24Proper Positioning and Restraint of a Rat Hind Limb for Focused High Resolution Imaging of Bone Micro-architecture Using In Vivo Micro-computed Tomography
Published on: November 22, 2017
07:53Peptides from Phage Display Library Modulate Gene Expression in Mesenchymal Cells and Potentiate Osteogenesis in Unicortical Bone Defects
Published on: December 10, 2010
Related Concept Videos
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
Bone Remodeling
Osteoclasts in Bone Remodeling
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Bioavailability Study Design: Healthy Subjects Versus Patients